It is important to always follow professional guidance to avoid complications
Image Credit: algae / Shutterstock.com The future of oral incretins Emerging oral incretins signal a transition to scalable, needle-free therapies designed to sustain high efficacy while improving global access
Zhao X, Yang Y, Sun BF, Shi Y, Yang X, Xiao W, et al
Previously, the only way a Medicare patient could access semaglutide was if they had a type 2 diabetes diagnosis, in which case their doctor could prescribe Ozempic (semaglutide at the 0.5 mg, 1 mg, or 2 mg dose approved for diabetes)
doi: Moiz, A., Filion, K.B., Tsoukas, M.A., Yu, O.HY., Peters, T.M
How to Start GLP-1 Treatment Without Insurance: The PlexusDx Process Accessing GLP-1 medication through PlexusDx requires no insurance verification, membership enrollment, or prior authorization delays